• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

影响因房颤和房扑急诊就诊患者口服抗凝药物处方的因素。

Factors Influencing Oral Anticoagulation Prescription for Patients Presenting to Emergency Departments With Atrial Fibrillation and Flutter.

机构信息

Libin Cardiovascular Institute of Alberta, Department of Cardiac Sciences, University of Calgary, Calgary, Alberta, Canada.

Department of Emergency Medicine, University of Calgary, Calgary, Alberta, Canada.

出版信息

Can J Cardiol. 2018 Jun;34(6):804-807. doi: 10.1016/j.cjca.2018.03.009. Epub 2018 Mar 24.

DOI:10.1016/j.cjca.2018.03.009
PMID:29801744
Abstract

Atrial fibrillation and atrial flutter (AF/AFL) are associated with an increased risk of stroke and systemic embolism. However, many patients are not started on guideline-recommended oral anticoagulation (OAC). We determined factors associated with initiation of OAC in eligible patients presenting to emergency departments. This retrospective cohort included patients with electrocardiogram (ECG)-documented AF/AFL presenting to 4 urban emergency departments in 2015. Presenting diagnoses, admission status, and comorbidities were determined by chart review. The primary outcome was OAC prescription within 90 days of ED presentation in guideline-eligible patients not previously on OAC. Of 4948 patients presenting to emergency departments with ECG-documented AF/AFL, we identified 2059 patients with Congestive Heart failure, Age (≥65),Diabetes, and Stroke (CHADS-65) score ≥1 not previously on OAC. Of those patients, 1287 (62.5%) were admitted, and 772 (37.5%) were discharged from the emergency department. Within 90 days of discharge, 663 (32.2%) patients were initiated on OAC. On multivariable analysis, hospitalization (odds ratio [OR] 1.31; 95% confidence interval [CI] 1.05-1.63, P = 0.02), presenting diagnosis of AF/AFL (OR 4.56, 95% CI 3.60-5.79, P < 0.01), and higher CHADS-65 score (OR 1.14 per point, 95% CI 1.04-1.25, P < 0.01) were associated with increased rates of OAC initiation. However, there was no association with individual components of the CHADS-65 score. Guideline-directed OAC is infrequently initiated in eligible patients within 90 days of presenting to emergency departments. The strongest factors associated with OAC initiation rates were hospitalization or having primary presenting diagnoses in emergency departments of AF/AFL after adjusting for other important characteristics. New interventions are required to improve appropriate OAC initiation in patients with AF/AFL.

摘要

心房颤动和心房扑动(AF/AFL)与中风和全身性栓塞的风险增加有关。然而,许多患者并未开始接受指南推荐的口服抗凝治疗(OAC)。我们确定了在符合条件的急诊科就诊的患者中开始 OAC 的相关因素。这项回顾性队列研究纳入了 2015 年在 4 个城市急诊科就诊的心电图(ECG)记录的 AF/AFL 患者。通过病历回顾确定就诊诊断、入院状态和合并症。主要结局是在没有接受 OAC 的指南合格患者中,在急诊科就诊后 90 天内开始使用 OAC。在因心电图记录的 AF/AFL 而就诊急诊科的 4948 名患者中,我们确定了 2059 名未接受 OAC 治疗且 CHADS-65 评分≥1 的充血性心力衰竭、年龄(≥65 岁)、糖尿病和中风患者。这些患者中,1287 人(62.5%)住院,772 人(37.5%)从急诊科出院。出院后 90 天内,有 663 名患者开始接受 OAC。多变量分析显示,住院治疗(比值比[OR]1.31;95%置信区间[CI]1.05-1.63,P=0.02)、AF/AFL 的就诊诊断(OR 4.56,95%CI 3.60-5.79,P<0.01)和更高的 CHADS-65 评分(OR 每点 1.14,95%CI 1.04-1.25,P<0.01)与 OAC 开始率的增加相关。然而,CHADS-65 评分的各个组成部分与 OAC 起始率无关。在急诊科就诊后 90 天内,指南指导的 OAC 很少在符合条件的患者中开始。在调整其他重要特征后,与 OAC 起始率最相关的因素是住院治疗或在急诊科以 AF/AFL 为主要就诊诊断。需要新的干预措施来改善 AF/AFL 患者的适当 OAC 起始治疗。

相似文献

1
Factors Influencing Oral Anticoagulation Prescription for Patients Presenting to Emergency Departments With Atrial Fibrillation and Flutter.影响因房颤和房扑急诊就诊患者口服抗凝药物处方的因素。
Can J Cardiol. 2018 Jun;34(6):804-807. doi: 10.1016/j.cjca.2018.03.009. Epub 2018 Mar 24.
2
Effects of a reminder to initiate oral anticoagulation in patients with atrial fibrillation/atrial flutter discharged from the emergency department: REMINDER study.急诊科出院的心房颤动/心房扑动患者口服抗凝启动提醒的效果:REMINDER研究
CJEM. 2018 Nov;20(6):841-849. doi: 10.1017/cem.2018.415. Epub 2018 Oct 8.
3
Missed opportunities for appropriate anticoagulation among emergency department patients with uncomplicated atrial fibrillation or flutter.急诊未合并房扑或房颤患者中适当抗凝治疗的错失机会。
Ann Emerg Med. 2013 Dec;62(6):557-565.e2. doi: 10.1016/j.annemergmed.2013.04.004. Epub 2013 May 24.
4
Evaluation of Adherence to Guideline-Directed Antithrombotic Therapy for Atrial Fibrillation at Hospital Discharge.出院时房颤患者遵循指南指导的抗栓治疗情况评估。
J Cardiovasc Pharmacol Ther. 2018 Nov;23(6):502-508. doi: 10.1177/1074248418778804. Epub 2018 May 27.
5
Outcomes of Patients With Atrial Fibrillation Newly Recommended for Oral Anticoagulation Under the 2014 American Heart Association/American College of Cardiology/Heart Rhythm Society Guideline.2014 年美国心脏协会/美国心脏病学会/心律学会指南新推荐口服抗凝治疗的心房颤动患者的结局。
J Am Heart Assoc. 2018 Jan 4;7(1):e007881. doi: 10.1161/JAHA.117.007881.
6
Identification and early anticoagulation in patients with atrial fibrillation in the emergency department.急诊科心房颤动患者的识别与早期抗凝治疗
Am J Emerg Med. 2021 Jun;44:315-322. doi: 10.1016/j.ajem.2020.04.019. Epub 2020 Apr 10.
7
Flaws in Anticoagulation Strategies in Patients With Atrial Fibrillation at Hospital Discharge.房颤患者出院时抗凝策略的缺陷。
J Cardiovasc Pharmacol Ther. 2019 May;24(3):225-232. doi: 10.1177/1074248418821712. Epub 2019 Jan 1.
8
Substantial differences in initiation of oral anticoagulant therapy and clinical outcome among non-valvular atrial fibrillation patients treated in inpatient and outpatient settings.非瓣膜性心房颤动患者在住院和门诊环境中接受治疗时,口服抗凝药物治疗的起始和临床结局存在显著差异。
Europace. 2016 Apr;18(4):492-500. doi: 10.1093/europace/euv242. Epub 2015 Oct 5.
9
Practice Gap in Atrial Fibrillation Oral Anticoagulation Prescribing at Emergency Department Home Discharge.在急诊科出院时对心房颤动患者进行口服抗凝治疗的实践差距。
West J Emerg Med. 2020 Jun 29;21(4):924-934. doi: 10.5811/westjem.2020.3.45135.
10
Contemporary Trends in Oral Anticoagulant Prescription in Atrial Fibrillation Patients at Low to Moderate Risk of Stroke After Guideline-Recommended Change in Use of the CHADS to the CHADS-VASc Score for Thromboembolic Risk Assessment: Analysis From the National Cardiovascular Data Registry's Outpatient Practice Innovation and Clinical Excellence Atrial Fibrillation Registry.在采用CHADS-VASc评分替代CHADS评分进行血栓栓塞风险评估的指南推荐更改后,低至中度卒中风险心房颤动患者口服抗凝药处方的当代趋势:来自国家心血管数据注册中心门诊实践创新与临床卓越心房颤动注册研究的分析
Circ Cardiovasc Qual Outcomes. 2017 May;10(5). doi: 10.1161/CIRCOUTCOMES.116.003476.

引用本文的文献

1
Geographic and temporal variation in the treatment and outcomes of atrial fibrillation: a population-based analysis of national quality indicators.基于人群的国家质量指标分析:房颤治疗和结局的地域和时间变化。
CMAJ Open. 2022 Aug 2;10(3):E702-E713. doi: 10.9778/cmajo.20210246. Print 2022 Jul-Sep.
2
Management of Atrial Fibrillation in the Emergency Department.急诊科心房颤动的管理。
Curr Cardiol Rep. 2021 Oct 16;23(12):179. doi: 10.1007/s11886-021-01611-2.
3
Non-adherence to Thromboprophylaxis Guidelines in Atrial Fibrillation: A Narrative Review of the Extent of and Factors in Guideline Non-adherence.
心房颤动患者抗凝预防指南的依从性:关于指南不依从程度及因素的叙述性综述
Am J Cardiovasc Drugs. 2021 Jul;21(4):419-433. doi: 10.1007/s40256-020-00457-3. Epub 2020 Dec 28.
4
Impact of a Multidisciplinary Treatment Pathway for Atrial Fibrillation in the Emergency Department on Hospital Admissions and Length of Stay: Results of a Multi-Center Study.多学科房颤急诊治疗路径对住院和住院时间的影响:一项多中心研究的结果。
J Am Heart Assoc. 2019 Sep 17;8(18):e012656. doi: 10.1161/JAHA.119.012656. Epub 2019 Sep 12.